Mycobacterium tuberculosis is a leading AIDS-related infectious disease killer worldwide. Tuberculosis is a disease of multiple pathologic stages, and hence M. tb. must possess multiple adaptive genetic strategies to survive in these differing environments. Understanding the organism's pathogenesis mechanisms during these disease stages is the surest way to develop better diagnostics, vaccines, and drugs which are critically needed for patients with TB and TB/HIV. We have genetically interrupted 5 M. tb. sigma factor genes, identified the genes which they regulate by using microarray technology and assessed their virulence in mice. Among these alternative sigma factors there is functional redundancy in that upon infection of mice 4 of the 5 mutants show the immunopathology phenotype of attenuation in which mycobacterial counts are maintained at high level but there is a significant delay in mortality and in disease progression in the lungs. In the first aim, we will explore the immunopathology defect demonstrated by several of the sigma factor knockout mutants. The roles of known mediators of TB control such as nitric oxide, TNF-alpha, interferon-gamma and phagocyte oxidase will be examined using the M. tb. deltasigH and other knockout mutants which display the immunopathology phenotype. Second, we will refine our understanding of these sigma factor regulons by studying expression profiles under stress conditions, by biochemical analysis of transcription, by constructing double knockout mutants, and through conditional expression of sigma factors. We will address whether there is sufficient ECF promoter consensus degeneracy to permit redundant sigma factor control of dependent genes or whether there are distal mediators which remain to be discovered. Finally, in the 3rd aim we will explore the modulation of sigma factor activity by studying anti-sigma factors. We will study the effect of AsiA, a phage-encoded anti-sigma factor which binds to RNA polymerase, remodels it, and alters its promoter specificity. We will seek to determine whether AsiA or portions of it have a transcription-specificity modifying effect in mycobacteria. We will also study the role of a novel sigma factor-regulator in M. tb, Rv1364c, which our data show is required for resistance to SDS stress. Advancing our understanding ofM. tb sigma factors and their related regulators will help establish key adaptive mechanisms in the pathogenesis of TB.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
AIDS-associated Opportunistic Infections and Cancer Study Section (AOIC)
Program Officer
Lacourciere, Karen A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Johns Hopkins University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Ihms, Elizabeth A; Urbanowski, Michael E; Bishai, William R (2018) Diverse Cavity Types and Evidence that Mechanical Action on the Necrotic Granuloma Drives Tuberculous Cavitation. Am J Pathol 188:1666-1675
Amaral, Eduardo P; Riteau, Nicolas; Moayeri, Mahtab et al. (2018) Lysosomal Cathepsin Release Is Required for NLRP3-Inflammasome Activation by Mycobacterium tuberculosis in Infected Macrophages. Front Immunol 9:1427
Dey, Ruchi Jain; Dey, Bappaditya; Zheng, Yue et al. (2017) Inhibition of innate immune cytosolic surveillance by an M. tuberculosis phosphodiesterase. Nat Chem Biol 13:210-217
Rockwood, Neesha; Costa, Diego L; Amaral, Eduardo P et al. (2017) Mycobacterium tuberculosis Induction of Heme Oxygenase-1 Expression Is Dependent on Oxidative Stress and Reflects Treatment Outcomes. Front Immunol 8:542
Manson, Abigail L; Cohen, Keira A; Abeel, Thomas et al. (2017) Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance. Nat Genet 49:395-402
Gupta, Shashank; Winglee, Kathryn; Gallo, Richard et al. (2017) Bacterial subversion of cAMP signalling inhibits cathelicidin expression, which is required for innate resistance to Mycobacterium tuberculosis. J Pathol 242:52-61
Gupta, Shashank; Cheung, Laurene; Pokkali, Supriya et al. (2017) Suppressor Cell-Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis. J Infect Dis 215:1883-1887
Singh, Alok Kumar; Bishai, William R (2017) Partners in Crime: Phenolic Glycolipids and Macrophages. Trends Mol Med 23:981-983
Maiga, Mamoudou; Cohen, Keira; Baya, Bocar et al. (2016) Stool microbiome reveals diverse bacterial ureases as confounders of oral urea breath testing for Helicobacter pylori and Mycobacterium tuberculosis in Bamako, Mali. J Breath Res 10:036012
Ahidjo, Bintou A; Maiga, Mariama C; Ihms, Elizabeth A et al. (2016) The antifibrotic drug pirfenidone promotes pulmonary cavitation and drug resistance in a mouse model of chronic tuberculosis. JCI Insight 1:e86017

Showing the most recent 10 out of 99 publications